Relmada Therapeutics Files 8-K with Key Agreements and Equity Sales
Ticker: RLMD · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1553643
| Field | Detail |
|---|---|
| Company | Relmada Therapeutics, Inc. (RLMD) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, regulation-fd
TL;DR
Relmada filed an 8-K: material agreement, equity sales, and FD disclosure. Check for details.
AI Summary
On March 24, 2025, Relmada Therapeutics, Inc. filed an 8-K report detailing several key events. The filing indicates the entry into a material definitive agreement, unregistered sales of equity securities, and a Regulation FD disclosure. It also includes financial statements and exhibits, with the report being filed as of March 26, 2025.
Why It Matters
This 8-K filing signals significant corporate actions by Relmada Therapeutics, including potential new financing or strategic partnerships and the issuance of equity, which could impact its financial structure and stock.
Risk Assessment
Risk Level: medium — The filing involves unregistered sales of equity securities and material definitive agreements, which can introduce financial and operational risks.
Key Players & Entities
- RELMADA THERAPEUTICS, INC. (company) — Registrant
- March 24, 2025 (date) — Date of earliest event reported
- March 26, 2025 (date) — Filing date
- 2222 Ponce de Leon Blvd. , Floor 3 Coral Gables , FL 33134 (address) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Relmada Therapeutics?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
What type of equity securities were sold in the unregistered sale?
The filing mentions unregistered sales of equity securities but does not specify the type or amount.
What is the purpose of the Regulation FD Disclosure?
The filing indicates a Regulation FD Disclosure was made, but the specific content is not detailed in this summary.
When was Relmada Therapeutics, Inc. incorporated?
Relmada Therapeutics, Inc. was incorporated in Nevada.
What is the IRS Employer Identification Number for Relmada Therapeutics, Inc.?
The IRS Employer Identification Number for Relmada Therapeutics, Inc. is 45-5401931.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding RELMADA THERAPEUTICS, INC. (RLMD).